Cargando…
Presymptomatic cerebral blood flow changes in CHMP2B mutation carriers of familial frontotemporal dementia (FTD-3), measured with MRI
OBJECTIVES: To assess functional changes measured by cerebral blood flow (CBF) in the presymptomatic stage of frontotemporal dementia linked to chromosome 3 (FTD-3) caused by a truncating mutation in CHMP2B. DESIGN: Case–control study. SETTING: A memory clinic and tertiary referrals centre for demen...
Autores principales: | Lunau, Line, Mouridsen, Kim, Rodell, Anders, Østergaard, Leif, Nielsen, Jørgen Erik, Isaacs, Adrian, Johannsen, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3307039/ https://www.ncbi.nlm.nih.gov/pubmed/22422914 http://dx.doi.org/10.1136/bmjopen-2011-000368 |
Ejemplares similares
-
Frontotemporal Dementia Caused by CHMP2B Mutations
por: Isaacs, A.M, et al.
Publicado: (2011) -
Disruption of endocytic trafficking in frontotemporal dementia with CHMP2B mutations
por: Urwin, Hazel, et al.
Publicado: (2010) -
Cortical Frontoparietal Network Dysfunction in CHMP2B-Frontotemporal Dementia
por: Musaeus, Christian Sandøe, et al.
Publicado: (2021) -
CSF neurofilament light concentration is increased in presymptomatic CHMP2B mutation carriers
por: Rostgaard, Nina, et al.
Publicado: (2018) -
Frontotemporal dementia caused by CHMP2B mutation is characterised by neuronal lysosomal storage pathology
por: Clayton, Emma L., et al.
Publicado: (2015)